Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series
Go back to Enveric Biosciences Selects EB-003 as Lead Drug Candidate from EVM301 Series| (NASDAQ: ENVB) | Delayed: 1.37 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.37 | 52 Week High | $ | |||
| Open | $1.41 | 52 Week Low | $ | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 22,173 | |||||
